RESEARCH REPORT

In brief

In brief

  • The "Metaverse Continuum" is a spectrum of digitally enhanced worlds, realities and business models poised to revolutionize life and enterprise.
  • For the 1st time, we surveyed 100 biopharma and 100 MedTech execs on the role emerging technologies will have for future growth and competitiveness.
  • The metaverse will advance very quickly. Companies need to act now or find themselves operating in worlds designed by, and for, someone else.
  • Every life sciences leader must ask: What will be my organization’s role in this new continuum?


Welcome to the “Metaverse Continuum”

The Metaverse Continuum is a spectrum of digitally enhanced worlds, realities and business models poised to revolutionize life and enterprise.

The life sciences industry is on the threshold of a new decade of digital transformation, and at a defining moment for all leaders. The Metaverse Continuum will transform how businesses interact with customers and how work is done. Our two surveys of biopharma and medical technology executives confirm this:

91%

of MedTech executives believe the metaverse will have a positive impact on their organizations.

42%

of biopharma executives believe the metaverse will have a breakthrough or transformational impact on their organizations.

The Metaverse Continuum incorporates all digitally enhanced realities—both social and business-related. It touches all patients, healthcare professionals and enterprises—from reality to virtual and back. Like two hemispheres of a brain, the Metaverse Continuum uses a million connections to bring virtual and reality together.

For biopharma companies, it will profoundly affect what medicines and services they offer, how they make and distribute them and how they fundamentally operate their organizations. Patients and employees can expect vastly more personalized experiences, with the lines between virtual and real-world experiences blurred into a unified metaverse reality.

RELATED: Accenture Technology Vision for Biopharma 2022

For MedTech companies, the metaverse creates opportunities for truly humanized digital ecosystems that meet customer needs across the value chain—in sales, after-sales service, training and supply chain management. The metaverse should be viewed as a new interaction platform with as-yet uncharted possibilities that extend opportunities for creativity, innovation and commercial value.

RELATED: Accenture Technology Vision for MedTech 2022

Shalu Chadha

Managing Director – Life Sciences Lead, Technology


Tim Durst

Managing Director – Life Sciences, Global Medical Technology

MORE ON THIS TOPIC

Scientific innovations for more sustainable growth
Facing disruption, MedTechs need to transform now

Subscription Center
Stay in the know with our newsletter Stay in the know with our newsletter